Selection of antimalarial drug resistance after intermittent preventive treatment of infants and children (IPTi/c) in Senegal
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Selection of antimalarial drug resistance after intermittent preventive treatment of infants and children (IPTi/c) in Senegal. / Ndiaye, Magatte; Tine, Roger; Faye, Babacar; Ndiaye, Jean L; Diouf, Ibrahima; Lo, Aminata C; Sylla, Khadime; Dieng, Yemou; Hallett, Rachel; Alifrangis, Michael; Gaye, Oumar.
In: Comptes Rendus Biologies, Vol. 336, No. 5-6, 2013, p. 295-300.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Selection of antimalarial drug resistance after intermittent preventive treatment of infants and children (IPTi/c) in Senegal
AU - Ndiaye, Magatte
AU - Tine, Roger
AU - Faye, Babacar
AU - Ndiaye, Jean L
AU - Diouf, Ibrahima
AU - Lo, Aminata C
AU - Sylla, Khadime
AU - Dieng, Yemou
AU - Hallett, Rachel
AU - Alifrangis, Michael
AU - Gaye, Oumar
N1 - Copyright © 2013 Académie des sciences. Published by Elsevier SAS. All rights reserved.
PY - 2013
Y1 - 2013
N2 - Senegal has since 2003 used sulphadoxine-pyrimethamine (SP) for Intermittent Preventive Treatment (IPT) of malaria in risk groups. However, the large-scale IPT strategy may result in increasing drug resistance. Our study investigated the possible impact of SP-IPT given to infants and children on the prevalence of SP-resistant haplotypes in the Plasmodium falciparum genes Pfdhfr and Pfdhps, comparing sites with and without IPTi/c. P. falciparum positives samples (n=352) were collected from children under 5years of age during two cross-sectional surveys in 2010 and 2011 in three health districts (two on IPTi/c and one without IPTi/c intervention) located in the southern part of Senegal. The prevalence of SP-resistance-related haplotypes in Pfdhfr and Pfdhps was determined by nested PCR followed by sequence-specific oligonucleotide probe (SSOP)-ELISA. The prevalence of the Pfdhfr double mutant haplotypes (CNRN and CICN) was stable between years at
AB - Senegal has since 2003 used sulphadoxine-pyrimethamine (SP) for Intermittent Preventive Treatment (IPT) of malaria in risk groups. However, the large-scale IPT strategy may result in increasing drug resistance. Our study investigated the possible impact of SP-IPT given to infants and children on the prevalence of SP-resistant haplotypes in the Plasmodium falciparum genes Pfdhfr and Pfdhps, comparing sites with and without IPTi/c. P. falciparum positives samples (n=352) were collected from children under 5years of age during two cross-sectional surveys in 2010 and 2011 in three health districts (two on IPTi/c and one without IPTi/c intervention) located in the southern part of Senegal. The prevalence of SP-resistance-related haplotypes in Pfdhfr and Pfdhps was determined by nested PCR followed by sequence-specific oligonucleotide probe (SSOP)-ELISA. The prevalence of the Pfdhfr double mutant haplotypes (CNRN and CICN) was stable between years at
U2 - 10.1016/j.crvi.2013.04.016
DO - 10.1016/j.crvi.2013.04.016
M3 - Journal article
C2 - 23916206
VL - 336
SP - 295
EP - 300
JO - Comptes Rendus - Academie des Sciences, Serie III: Sciences de la Vie
JF - Comptes Rendus - Academie des Sciences, Serie III: Sciences de la Vie
SN - 0764-4469
IS - 5-6
ER -
ID: 48881262